Pacific Biosciences of California (PACB) News Today → What is Medicare Supplement Insurance? (From Tranzact) (Ad) Free PACB Stock Alerts $1.47 +0.09 (+6.52%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineJP Morgan Downgrades Pacific Biosciences of California (PACB)msn.com - April 23 at 5:06 AMPacific Biosciences of California, Inc. (NASDAQ:PACB) Given Consensus Rating of "Moderate Buy" by Analystsamericanbankingnews.com - April 23 at 4:26 AMPacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Consensus Recommendation of "Moderate Buy" from Analystsmarketbeat.com - April 23 at 4:26 AMPacific Biosciences of California (NASDAQ:PACB) Downgraded to Neutral at JPMorgan Chase & Co.americanbankingnews.com - April 23 at 3:32 AMPacific Biosciences of California (NASDAQ:PACB) Lowered to "Neutral" at JPMorgan Chase & Co.marketbeat.com - April 22 at 8:29 AMPacific Biosciences of California (NASDAQ:PACB) Stock Rating Lowered by The Goldman Sachs Groupamericanbankingnews.com - April 20 at 6:08 AMPacific Biosciences of California (NASDAQ:PACB) PT Lowered to $2.50 at TD Cowenamericanbankingnews.com - April 20 at 6:08 AMPacific Biosciences of California (NASDAQ:PACB) PT Lowered to $8.00americanbankingnews.com - April 20 at 6:08 AMPacific Biosciences of California (NASDAQ:PACB) PT Lowered to $2.50americanbankingnews.com - April 20 at 4:52 AMPacBio cut to Neutral at Goldman Sachs after guidance cutmsn.com - April 18 at 2:47 PMAnalysts Offer Insights on Healthcare Companies: Pacific Biosciences (PACB) and Eli Lilly & Co (LLY)markets.businessinsider.com - April 18 at 2:47 PMPacific Biosciences of California (NASDAQ:PACB) Upgraded to "Sell" at StockNews.comamericanbankingnews.com - April 18 at 5:56 AMPacific Biosciences of California (PACB) Price Target Decreased by 18.15% to 9.01msn.com - April 18 at 12:11 AMPacific Biosciences of California (NASDAQ:PACB) Lifted to "Sell" at StockNews.commarketbeat.com - April 17 at 11:13 PMPacific Biosciences of California (NASDAQ:PACB) Price Target Cut to $2.50 by Analysts at TD Cowenmarketbeat.com - April 17 at 4:27 PMMid-Week Wednesday's Most Active Buysbaystreet.ca - April 17 at 2:10 PMPacific Biosciences of California, Inc.: PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidancefinanznachrichten.de - April 16 at 5:20 PMThe Cathie Wood Stock Shuffle: 4 Names She's Loving, 3 She's Leavinginvestorplace.com - April 16 at 2:47 PMPacBio falls after issuing guidance below expectationsmsn.com - April 16 at 12:19 PMPacBio Q1 Prel. Revenue Nearly Flat, Annual Revenue Outlook Below View; Stock Downmarkets.businessinsider.com - April 16 at 12:19 PMPacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidancefinance.yahoo.com - April 16 at 12:19 PMMirae Asset Global Investments Co. Ltd. Has $9.09 Million Stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB)marketbeat.com - April 13 at 5:59 AMPacific Biosciences of California (NASDAQ:PACB) Hits New 52-Week Low at $3.15marketbeat.com - April 12 at 3:59 PMPacific Biosciences of California (NASDAQ:PACB) Stock Price Down 8.3% Following Analyst Downgrademarketbeat.com - April 10 at 12:57 PMMoody Aldrich Partners LLC Makes New Investment in Pacific Biosciences of California, Inc. (NASDAQ:PACB)marketbeat.com - April 9 at 1:32 PMNASDAQ:PACB (Pacific Biosciences Of California)fool.ca - April 9 at 1:16 PMPacific Biosciences of California (NASDAQ:PACB) Shares Gap Up to $3.35marketbeat.com - April 8 at 11:36 AMPacific Biosciences of California (NASDAQ:PACB) Trading 4.5% Higher marketbeat.com - April 4 at 2:25 PMSaviynt Recognized on Inc. Magazine's List of the Pacific Region's Fastest-Growing Private Companiestmcnet.com - April 3 at 1:40 AMPacific Biosciences of California (NASDAQ:PACB) Hits New 52-Week Low at $3.42marketbeat.com - April 2 at 10:47 AMPacific Biosciences of California, Inc. (NASDAQ:PACB) Given Consensus Recommendation of "Moderate Buy" by Brokeragesmarketbeat.com - March 29 at 4:26 AMARK Investment Management LLC Has $338.49 Million Stock Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB)marketbeat.com - March 28 at 6:39 AMPacific Biosciences of California (NASDAQ:PACB) Shares Up 4.8%marketbeat.com - March 27 at 12:44 PMEstonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomesprnewswire.com - March 27 at 8:00 AMAssenagon Asset Management S.A. Has $29.84 Million Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB)marketbeat.com - March 27 at 6:42 AMPacific Biosciences of California (NASDAQ:PACB) Hits New 52-Week Low at $3.46marketbeat.com - March 26 at 4:46 PMPacific Biosciences of California (NASDAQ:PACB) Shares Gap Up to $3.68marketbeat.com - March 25 at 11:54 AMPacific Biosciences of California, Inc.: PacBio Grants Equity Incentive Award to New Employeefinanznachrichten.de - March 23 at 9:21 AMPacBio Grants Equity Incentive Award to New Employeeprnewswire.com - March 22 at 4:30 PM11 Oversold NASDAQ Stocks To Buy Right Nowfinance.yahoo.com - March 21 at 2:33 AMPacific Biosciences of California (NASDAQ:PACB) Stock Rating Upgraded by StockNews.commarketbeat.com - March 20 at 3:29 AMPacific Biosciences of California (NASDAQ:PACB) Hits New 1-Year Low at $3.55marketbeat.com - March 19 at 11:51 AMPacific Biosciences of California, Inc. (NASDAQ:PACB) Insider Michele Farmer Sells 2,968 Sharesinsidertrades.com - March 16 at 11:16 AMSpecial Report: Pacific Marine & Supply Co. commemorates 80 years with donationbizjournals.com - March 15 at 7:51 PMSangamo Biosciences Earns Buy Rating on Breakthrough Brain-Targeting Gene Therapy Capsid and Strategic Advancementsmarkets.businessinsider.com - March 14 at 2:56 PMPacific Biosciences of California (NASDAQ:PACB) Reaches New 52-Week Low at $3.86marketbeat.com - March 13 at 12:32 PMHow Is The Market Feeling About Pacific Biosciences?benzinga.com - March 12 at 5:34 PMPacific Biosciences of California (NASDAQ:PACB) Shares Down 5% marketbeat.com - March 12 at 1:24 PMPacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutionsfinance.yahoo.com - March 12 at 12:34 PMPacific Biosciences of California (NASDAQ:PACB) Rating Increased to Sell at StockNews.commarketbeat.com - March 11 at 11:15 PM Get Pacific Biosciences of California News Delivered to You Automatically Sign up to receive the latest news and ratings for PACB and its competitors with MarketBeat's FREE daily newsletter. Email Address The Gold Grab of the Century (Ad)When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago. That's why we have released our Free Precious Metals Investment Guide. PACB Media Mentions By Week PACB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PACB News Sentiment▼-0.030.33▲Average Medical News Sentiment PACB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PACB Articles This Week▼64▲PACB Articles Average Week Get Pacific Biosciences of California News Delivered to You Automatically Sign up to receive the latest news and ratings for PACB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: NAUT News Today AKYA News Today QTRX News Today HBIO News Today SEER News Today LAB News Today BNGO News Today CTKB News Today AXDX News Today EYPT News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PACB) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe World's First "$20 Trillion Drug?"Behind the MarketsUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacific Biosciences of California, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
